{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:21:52Z","timestamp":1784762512733,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science, Technology & Innovation Funding Authority"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance is one of the ten major public health threats facing humanity, especially in developing countries. Identification of the pathogens responsible for different microbial infections and antimicrobial resistance patterns are important to help clinicians to choose the correct empirical drugs and provide optimal patient care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>During the period from November 2020 to January 2021, one hundred microbial isolates were collected randomly from different specimens from some hospitals in Cairo, Egypt. Sputum and chest specimens were from COVID-19 patients. Antimicrobial susceptibility testing was performed according to CLSI guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most microbial infections were more common in males and in elderly people over 45 years of age. They were caused by Gram-negative, Gram-positive bacteria, and yeast isolates that represented 69%, 15%, and 16%, respectively. Uropathogenic <jats:italic>Escherichia coli<\/jats:italic> (35%) were the most prevalent microbial isolates and showed high resistance rates towards penicillin, ampicillin, and cefixime, followed by <jats:italic>Klebsiella<\/jats:italic> spp. (13%) and <jats:italic>Candida<\/jats:italic> spp. (16%). Of all microbial isolates, <jats:italic>Acinetobacter<\/jats:italic> spp., <jats:italic>Serratia<\/jats:italic> spp., <jats:italic>Hafnia alvei<\/jats:italic>, and <jats:italic>Klebsiella ozaenae<\/jats:italic> were extremely multidrug-resistant (MDR) and have resisted all antibiotic classes used, except for glycylcycline, in varying degrees. <jats:italic>Acinetobacter<\/jats:italic> spp., <jats:italic>Serratia<\/jats:italic> spp., and <jats:italic>Candida<\/jats:italic> spp. were secondary microbial infections in COVID-19 patients, while <jats:italic>H. alvei<\/jats:italic> was a bloodstream infection isolate and <jats:italic>K. ozaenae<\/jats:italic> was recorded in most infections. Moreover, about half of <jats:italic>Staphylococcus aureus<\/jats:italic> strains were MRSA isolates and reported low rates of resistance to glycylcycline and linezolid. In comparison, <jats:italic>Candida<\/jats:italic> spp. showed high resistance rates between 77 and 100% to azole drugs and terbinafine, while no resistance rate towards nystatin was reported. Indeed, glycylcycline, linezolid, and nystatin were considered the drugs of choice for the treatment of MDR infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The prevalence of antimicrobial resistance in some Egyptian hospitals was high among Gram-negative, Gram-positive bacteria, and <jats:italic>candida<\/jats:italic> spp. The high resistance pattern \u2014especially in secondary microbial infections in COVID-19 patients\u2014 to most antibiotics used is a matter of great concern, portends an inevitable catastrophe, and requires continuous monitoring to avoid the evolution of new generations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08397-4","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:15:18Z","timestamp":1687425318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Emergence of microbial infections in some hospitals of Cairo, Egypt: studying their corresponding antimicrobial resistance profiles"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2709-9981","authenticated-orcid":false,"given":"Asmaa K.","family":"Helmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa M.","family":"Sidkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy E.","family":"El-Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5133-249X","authenticated-orcid":false,"given":"Ahmed G.","family":"Hegazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"8397_CR1","doi-asserted-by":"publisher","unstructured":"Gidey K, Gidey MT, Hailu BY, Gebreamlak ZB, Niriayo YL. Clinical and economic burden of healthcare-associated infections: A prospective cohort study. Plos one. 2023;18(2):e0282141. https:\/\/doi.org\/10.1371\/journal.pone.0282141.","DOI":"10.1371\/journal.pone.0282141"},{"key":"8397_CR2","doi-asserted-by":"publisher","unstructured":"Hassan R, El-Gilany AH, El-Mashad N, Azim DA. An overview of healthcare-associated infections in a tertiary care hospital in Egypt. Infection Prevention in Practice. 2020;2(3):100059. https:\/\/doi.org\/10.1016\/j.infpip.2020.100059.","DOI":"10.1016\/j.infpip.2020.100059"},{"key":"8397_CR3","doi-asserted-by":"publisher","unstructured":"Stevens MP, Doll M, Pryor R, Godbout E, Cooper K, Bearman G. Impact of COVID-19 on traditional healthcare-associated infection prevention efforts. Infect Control Hosp Epidemiol. 2020;41(8):946\u20137. https:\/\/doi.org\/10.1017\/ice.2020.141.","DOI":"10.1017\/ice.2020.141"},{"key":"8397_CR4","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"20","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infection and drug resistance. 2019;20:3903\u201310. https:\/\/doi.org\/10.2147\/IDR.S234610.","journal-title":"Dec"},{"key":"8397_CR5","doi-asserted-by":"publisher","unstructured":"de Kraker ME, Stewardson AJ, Harbarth S. Will 10 million people die a year due to antimicrobial resistance by 2050?. PLoS Med 2016;13(11):e1002184. https:\/\/doi.org\/10.1371\/journal.pmed.1002184.","DOI":"10.1371\/journal.pmed.1002184"},{"key":"8397_CR6","doi-asserted-by":"publisher","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and global health. 2015;109(7):309 \u2013 18. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030.","DOI":"10.1179\/2047773215Y.0000000030"},{"key":"8397_CR7","doi-asserted-by":"publisher","unstructured":"Moustafa AA, Raouf MM, El-Dawy MS. Bacterial healthcare-associated infection rates among children admitted to Pediatric Intensive Care Unit of a Tertiary Care Hospital, Egypt. Alexandria Journal of Pediatrics. 2017;30(3):100. https:\/\/doi.org\/10.4103\/AJOP.AJOP_2_18.","DOI":"10.4103\/AJOP.AJOP_2_18"},{"key":"8397_CR8","unstructured":"Sikora A, Zahra F. Nosocomial infections. InStatPearls [Internet] 2022 Feb 28. StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559312\/."},{"key":"8397_CR9","doi-asserted-by":"crossref","unstructured":"Rerambiah LK, Ndong JC, Massoua PM, Medzegue S, Elisee-Ndam M, Mintsa-Ndong A, Siawaya JF. Antimicrobial profiles of bacterial clinical isolates from the Gabonese National Laboratory of Public Health: data from routine activity. International Journal of Infectious Diseases. 2014;29:48\u201353. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25449235\/.","DOI":"10.1016\/j.ijid.2014.01.015"},{"key":"8397_CR10","doi-asserted-by":"crossref","unstructured":"Faksri K, Kaewkes W, Chaicumpar K, Chaimanee P, Wongwajana S. Epidemiology and identification of potential fungal pathogens causing invasive fungal infections in a tertiary care hospital in northeast Thailand. Medical Mycology. 2014;52(8):810-8. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25231771\/.","DOI":"10.1093\/mmy\/myu052"},{"key":"8397_CR11","doi-asserted-by":"publisher","unstructured":"Mishra MP, Debata NK, Padhy RN. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pacific journal of tropical biomedicine. 2013;3(4):315 \u2013 24. https:\/\/doi.org\/10.1016\/S2221-1691(13)60071-4.","DOI":"10.1016\/S2221-1691(13)60071-4"},{"key":"8397_CR12","doi-asserted-by":"crossref","unstructured":"Tan GL, Peterson EM. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures. Journal of clinical microbiology. 2005;43(4):1727-31. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15814992\/.","DOI":"10.1128\/JCM.43.4.1727-1731.2005"},{"key":"8397_CR13","doi-asserted-by":"publisher","unstructured":"Spanu T, Sanguinetti M, Ciccaglione D, D\u2019Inzeo T, Romano L, Leone F, Fadda G. Use of the VITEK 2 system for rapid identification of clinical isolates of staphylococci from bloodstream infections. J Clin Microbiol. 2003;41(9):4259\u201363. https:\/\/doi.org\/10.1128\/JCM.41.9.4259-4263.2003.","DOI":"10.1128\/JCM.41.9.4259-4263.2003"},{"key":"8397_CR14","doi-asserted-by":"publisher","unstructured":"Nassar MS, Hazzah WA, Bakr WM. Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be?. Journal of the Egyptian Public Health Association. 2019;94(1):1\u20135. Available from: https:\/\/jepha.springeropen.com\/articles\/https:\/\/doi.org\/10.1186\/s42506-018-0006-1.","DOI":"10.1186\/s42506-018-0006-1"},{"key":"8397_CR15","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne, PA: CLSI. 2020. Available from: https:\/\/www.nih.org.pk\/wp-content\/uploads\/2021\/02\/CLSI-2020.pdf."},{"key":"8397_CR16","doi-asserted-by":"publisher","unstructured":"Khadka S, Sherchand JB, Pokhrel BM, Parajuli K, Mishra SK, Sharma S, Shah N, Kattel HP, Dhital S, Khatiwada S, Parajuli N. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. BMC research notes. 2017;10(1):1\u20135. Available from: https:\/\/bmcresnotes.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13104-017-2547-3.","DOI":"10.1186\/s13104-017-2547-3"},{"key":"8397_CR17","unstructured":"Weinstein MP, Patel JB, Bobenchik AM, Campeau S, Cullen SK, Galas MF, Gold H, Humphries RM, Kirn TJ, Lewis Ii JS, Limbago B. M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application. Performance standards for antimicrobial susceptibility testing performance standards for antimicrobial susceptibility testing. 2020. Available from: https:\/\/clsi.org\/media\/3481\/m100ed30_sample.pdf."},{"key":"8397_CR18","unstructured":"World Health Organization (WHO). Antibiotic Resistance. 2020. Available online at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance."},{"key":"8397_CR19","doi-asserted-by":"crossref","unstructured":"Fordyce CB, Katz JN, Alviar CL, Arslanian-Engoren C, Bohula EA, Geller BJ, Hollenberg SM, Jentzer JC, Sims DB, Washam JB, van Diepen S. Prevention of complications in the cardiac intensive care unit: a scientific statement from the American Heart Association. Circulation. 2020;142(22):e379-406. Available from: https:\/\/www.ahajournals.org\/doi\/suppl\/10.1161\/CIR.0000000000000909.","DOI":"10.1161\/CIR.0000000000000909"},{"key":"8397_CR20","doi-asserted-by":"publisher","unstructured":"Dat VQ, Vu HN, Nguyen The H, Nguyen HT, Hoang LB, Vu Tien Viet D, Bui CL, Van Nguyen K, Nguyen TV, Trinh DT, Torre A. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC infectious diseases. 2017;17:1\u20131. Available from: https:\/\/link.springer.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-017-2582-7.","DOI":"10.1186\/s12879-017-2582-7"},{"key":"8397_CR21","doi-asserted-by":"publisher","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JP, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical microbiology and infection. 2020;26(12):1622-9. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016.","DOI":"10.1016\/j.cmi.2020.07.016"},{"key":"8397_CR22","doi-asserted-by":"publisher","unstructured":"Mege JL, Bretelle F, Leone M. Sex and bacterial infectious diseases. New microbes and new infections. 2018;26:S100-3. https:\/\/doi.org\/10.1016\/J.NMNI.2018.05.010.","DOI":"10.1016\/J.NMNI.2018.05.010"},{"key":"8397_CR23","doi-asserted-by":"publisher","unstructured":"Bereshchenko O, Bruscoli S, Riccardi C. Glucocorticoids, sex hormones, and immunity. Frontiers in immunology. 2018;9:1332. https:\/\/doi.org\/10.3389\/FIMMU.2018.01332\/BIBTEX.","DOI":"10.3389\/FIMMU.2018.01332\/BIBTEX"},{"key":"8397_CR24","doi-asserted-by":"publisher","unstructured":"Lawton G. You\u2019re only as young as your immune system. New Scientist. 2020;245(3275):44 \u2013 8. https:\/\/doi.org\/10.1016\/S0262-4079(20)30646-1.","DOI":"10.1016\/S0262-4079(20)30646-1"},{"key":"8397_CR25","doi-asserted-by":"crossref","unstructured":"Vasudevan R. Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp. 2014;1(2):00008. Available from: https:\/\/medcraveonline.com\/JMEN\/JMEN-01-00008.php.","DOI":"10.15406\/jmen.2014.01.00008"},{"key":"8397_CR26","doi-asserted-by":"publisher","unstructured":"Storme O, Tir\u00e1n Saucedo J, Garcia-Mora A, Dehesa-D\u00e1vila M, Naber KG. Risk factors and predisposing conditions for urinary tract infection. Therapeutic advances in urology. 2019;11:1756287218814382. https:\/\/doi.org\/10.1177\/1756287218814382.","DOI":"10.1177\/1756287218814382"},{"key":"8397_CR27","doi-asserted-by":"publisher","unstructured":"Seifu WD, Gebissa AD. Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia. BMC infectious diseases. 2018;18:1\u20139. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-017-2911-x.","DOI":"10.1186\/s12879-017-2911-x"},{"key":"8397_CR28","doi-asserted-by":"publisher","unstructured":"Kline KA, Lewis AL. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Urinary tract infections: molecular pathogenesis and clinical management. 2017:459\u2013502. https:\/\/doi.org\/10.1128\/MICROBIOLSPEC.UTI-0012-2012.","DOI":"10.1128\/MICROBIOLSPEC.UTI-0012-2012"},{"key":"8397_CR29","doi-asserted-by":"publisher","unstructured":"Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, Doosti Z, Ej Golzari S. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC infectious diseases. 2020;20(1):1\u20137. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-020-05374-z.","DOI":"10.1186\/s12879-020-05374-z"},{"key":"8397_CR30","doi-asserted-by":"crossref","unstructured":"Mahendra M, Jayaraj BS, Lokesh KS, Chaya SK, Veerapaneni VV, Limaye S, Dhar R, Swarnakar R, Ambalkar S, Mahesh PA, Indian Society of Critical Care Medicine. Antibiotic prescription, organisms and its resistance pattern in patients admitted to respiratory ICU with respiratory infection in Mysuru. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of. 2018;22(4):223. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29743760\/.","DOI":"10.4103\/ijccm.IJCCM_409_17"},{"key":"8397_CR31","doi-asserted-by":"publisher","unstructured":"Timsit JF, Schwebel C, Styfalova L, Cornet M, Poirier P, Forrestier C, Ruckly S, Jacob MC, Souweine B. Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study. Intensive care medicine. 2019;45:834 \u2013 43. https:\/\/doi.org\/10.1007\/S00134-019-05622-0.","DOI":"10.1007\/S00134-019-05622-0"},{"key":"8397_CR32","doi-asserted-by":"crossref","unstructured":"Deku JG, Dakorah MP, Lokpo SY, Orish VN, Ussher FA, Kpene GE, Angmorkie Eshun V, Agyei E, Attivor W, Osei-Yeboah J. The epidemiology of bloodstream infections and antimicrobial susceptibility patterns: A nine-year retrospective study at St. Dominic Hospital, Akwatia, Ghana. Journal of tropical medicine. 2019;2019. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31641359\/.","DOI":"10.1155\/2019\/6750864"},{"key":"8397_CR33","unstructured":"Haddadin Y, Annamaraju P, Regunath H. Central line associated blood stream infections. 2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430891\/."},{"key":"8397_CR34","doi-asserted-by":"crossref","unstructured":"Khurana S, Bhardwaj N, Kumari M, Malhotra R, Mathur P. Prevalence, etiology, and antibiotic resistance profiles of bacterial bloodstream infections in a tertiary care hospital in Northern India: a 4-year study. Journal of laboratory physicians. 2018;10(04):426 \u2013 31. Available from: http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/JLP.JLP_78_1.","DOI":"10.4103\/JLP.JLP_78_18"},{"key":"8397_CR35","doi-asserted-by":"crossref","unstructured":"Akinkunmi EO, Adesunkanmi AR, Lamikanra A. Pattern of pathogens from surgical wound infections in a Nigerian hospital and their antimicrobial susceptibility profiles. African health sciences. 2014;14(4):802-9. Available from: http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/JLP.JLP_78_18.","DOI":"10.4314\/ahs.v14i4.5"},{"key":"8397_CR36","doi-asserted-by":"publisher","unstructured":"Hassan MA, Abd El-Aziz S, Elbadry HM, Samy A, Tamer TM. Prevalence, antimicrobial resistance profile, and characterization of multi-drug resistant bacteria from various infected wounds in North Egypt. Saudi Journal of Biological Sciences. 2022;29(4):2978-88. https:\/\/doi.org\/10.1016\/j.sjbs.2022.01.015.","DOI":"10.1016\/j.sjbs.2022.01.015"},{"key":"8397_CR37","doi-asserted-by":"publisher","unstructured":"Bahrami S, Shafiee F, Hakamifard A, Fazeli H, Soltani R. Antimicrobial susceptibility pattern of carbapenemase-producing Gram-negative nosocomial bacteria at Al Zahra hospital, Isfahan, Iran. Iran J Microbiol 2021;13(1):50. https:\/\/doi.org\/10.18502\/IJM.V13I1.5492.","DOI":"10.18502\/IJM.V13I1.5492"},{"key":"8397_CR38","doi-asserted-by":"publisher","unstructured":"Namiganda V, Mina Y, Meklat A, Touati D, Bouras N, Barakate M, Sabaou N. Antibiotic Resistance Pattern of Acinetobacter baumannii strains isolated from different clinical specimens and their sensibility against bioactive molecules produced by Actinobacteria. Arabian Journal for Science and Engineering. 2019;44:6267-75. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s13369-019-03893-9.","DOI":"10.1007\/s13369-019-03893-9"},{"key":"8397_CR39","doi-asserted-by":"publisher","unstructured":"Agyepong N, Govinden U, Owusu-Ofori A, Essack SY. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana. Antimicrob Resist Infect Control 2018;7(1):1\u20138. https:\/\/doi.org\/10.1186\/S13756-018-0324-2.","DOI":"10.1186\/S13756-018-0324-2"},{"key":"8397_CR40","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"8397_CR41","doi-asserted-by":"crossref","unstructured":"Nag VL, Kaur N. Superinfections in COVID-19 patients: role of antimicrobials. Dubai Medical Journal. 2021;4(2):117 \u2013 26. Available from: https:\/\/www.karger.com\/Article\/FullText\/515067.","DOI":"10.1159\/000515067"},{"key":"8397_CR42","doi-asserted-by":"publisher","unstructured":"Abbott SL, Moler S, Green N, Tran RK, Wainwright K, Janda JM. Clinical and laboratory diagnostic characteristics and cytotoxigenic potential of Hafnia alvei and Hafnia paralvei strains. J Clin Microbiol. 2011;49(9):3122\u20136. https:\/\/doi.org\/10.1128\/JCM.00866-11.","DOI":"10.1128\/JCM.00866-11"},{"key":"8397_CR43","doi-asserted-by":"publisher","unstructured":"Singh AK, Das S, Kumar S, Gajamer VR, Najar IN, Lepcha YD, Tiwari HK, Singh S. Distribution of antibiotic-resistant Enterobacteriaceae pathogens in potable spring water of eastern Indian Himalayas: emphasis on virulence gene and antibiotic resistance genes in Escherichia coli. Frontiers in Microbiology. 2020;11:581072. Available from: https:\/\/doi.org\/10.3389\/FMICB.2020.581072\/FULL.","DOI":"10.3389\/FMICB.2020.581072\/FULL"},{"key":"8397_CR44","doi-asserted-by":"publisher","unstructured":"Ghenea AE, Cioboat\u0103 R, Droca\u015f AI, \u021aieranu EN, Vasile CM, Moro\u015fanu A, \u021aieranu CG, Salan AI, Popescu M, Turculeanu A, Padureanu V. Prevalence and antimicrobial resistance of Klebsiella strains isolated from a county hospital in Romania. Antibiot 2021;10(7):868. https:\/\/doi.org\/10.3390\/ANTIBIOTICS10070868.","DOI":"10.3390\/ANTIBIOTICS10070868"},{"key":"8397_CR45","doi-asserted-by":"publisher","unstructured":"Nirwati H, Sinanjung K, Fahrunissa F, Wijaya F, Napitupulu S, Hati VP, Hakim MS, Meliala A, Aman AT, Nuryastuti T. Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. InBMC proceedings 2019; 13(11):1\u20138. BioMed Central. https:\/\/doi.org\/10.1186\/S12919-019-0176-7.","DOI":"10.1186\/S12919-019-0176-7"},{"key":"8397_CR46","doi-asserted-by":"crossref","unstructured":"Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrobial Resistance & Infection Control. 2018;7(1):1\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30305891\/.","DOI":"10.1186\/s13756-018-0411-4"},{"key":"8397_CR47","doi-asserted-by":"publisher","unstructured":"Aabed K, Moubayed N, Alzahrani S. Antimicrobial resistance patterns among different Escherichia coli isolates in the Kingdom of Saudi Arabia. Saudi journal of biological sciences. 2021;28(7):3776-82. Available from: https:\/\/doi.org\/10.1016\/j.sjbs.2021.03.047.","DOI":"10.1016\/j.sjbs.2021.03.047"},{"key":"8397_CR48","doi-asserted-by":"publisher","unstructured":"Scudeller L, Righi E, Chiamenti M, Bragantini D, Menchinelli G, Cattaneo P, Giske CG, Lodise T, Sanguinetti M, Piddock LJ, Franceschi F. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents. 2021;57(5):106344. https:\/\/doi.org\/10.1016\/J.IJANTIMICAG.2021.106344.","DOI":"10.1016\/J.IJANTIMICAG.2021.106344"},{"key":"8397_CR49","doi-asserted-by":"crossref","unstructured":"Friedrich R, Rappold E, Bogdan C, Held J. Comparative analysis of the Wako \u03b2-glucan test and the Fungitell assay for diagnosis of candidemia and Pneumocystis jirovecii pneumonia. Journal of Clinical Microbiology. 2018;56(9):e00464-18. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29899003\/.","DOI":"10.1128\/JCM.00464-18"},{"key":"8397_CR50","doi-asserted-by":"publisher","unstructured":"Mirzaei A, Habibi M, Bouzari S, Asadi Karam MR. Characterization of antibiotic-susceptibility patterns, virulence factor profiles and clonal relatedness in Proteus mirabilis isolates from patients with urinary tract infection in Iran. Infection and drug resistance. 2019:3967\u201379. https:\/\/doi.org\/10.2147\/IDR.S230303.","DOI":"10.2147\/IDR.S230303"},{"key":"8397_CR51","doi-asserted-by":"publisher","unstructured":"Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):1\u20137. https:\/\/doi.org\/10.1186\/s12879-016-2082-1.","DOI":"10.1186\/s12879-016-2082-1"},{"key":"8397_CR52","doi-asserted-by":"crossref","unstructured":"Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC infectious diseases. 2020;20:1\u20131. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32000693\/.","DOI":"10.1186\/s12879-020-4811-8"},{"key":"8397_CR53","doi-asserted-by":"publisher","unstructured":"Solomon FB, Wadilo F, Tufa EG, Mitiku M. Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition. Antimicrob Resist Infect Control. 2017;6:1\u20137. https:\/\/doi.org\/10.1186\/s13756-017-0266.","DOI":"10.1186\/s13756-017-0266"},{"key":"8397_CR54","doi-asserted-by":"crossref","unstructured":"Sid Ahmed MA, Abdel Hadi H, Hassan AA, Abu Jarir S, Al-Maslamani MA, Eltai NO, Dousa KM, Hujer AM, Sultan AA, Soderquist B, Bonomo RA. Evaluation of in vitro activity of ceftazidime\/avibactam and ceftolozane\/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar. Journal of Antimicrobial Chemotherapy. 2019;74(12):3497 \u2013 504. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31504587\/.","DOI":"10.1093\/jac\/dkz379"},{"key":"8397_CR55","doi-asserted-by":"publisher","unstructured":"Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. Indian Journal of Burns. 2015;23(1):56. https:\/\/doi.org\/10.4103\/0971-653X.171656.","DOI":"10.4103\/0971-653X.171656"},{"key":"8397_CR56","unstructured":"Taylor TA, Unakal CG. Staphylococcus aureus. In StatPearls [Internet]. StatPearls Publishing. 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441868\/."},{"key":"8397_CR57","doi-asserted-by":"publisher","unstructured":"Y\u0131lmaz E, Aslanta\u015f \u00d6. Antimicrobial resistance and underlying mechanisms in Staphylococcus aureus isolates. Asian Pacific journal of tropical medicine. 2017;10(11):1059-64. https:\/\/doi.org\/10.1016\/J.APJTM.2017.10.003.","DOI":"10.1016\/J.APJTM.2017.10.003"},{"key":"8397_CR58","doi-asserted-by":"publisher","unstructured":"Li L, Dai JX, Xu L, Chen ZH, Li XY, Liu M, Wen YQ, Chen XD. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine. 2018;97(34). https:\/\/doi.org\/10.1097\/MD.0000000000011977.","DOI":"10.1097\/MD.0000000000011977"},{"key":"8397_CR59","doi-asserted-by":"crossref","unstructured":"Gu F, He W, Xiao S, Wang S, Li X, Zeng Q, Ni Y, Han L. Antimicrobial resistance and molecular epidemiology of Staphylococcus aureus causing bloodstream infections at Ruijin Hospital in Shanghai from 2013 to 2018. Scientific reports. 2020;10(1):1\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32265473\/.","DOI":"10.1038\/s41598-020-63248-5"},{"key":"8397_CR60","doi-asserted-by":"publisher","unstructured":"Xu Z, Shah HN, Misra R, Chen J, Zhang W, Liu Y, Cutler RR, Mkrtchyan HV. The prevalence, antibiotic resistance and mecA characterization of coagulase negative staphylococci recovered from non-healthcare settings in London, UK. Antimicrobial Resistance & Infection Control. 2018;7:1 \u2013 0. Available from: https:\/\/aricjournal.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13756-018-0367-4.","DOI":"10.1186\/s13756-018-0367-4"},{"key":"8397_CR61","doi-asserted-by":"publisher","unstructured":"Xu Y, Wang B, Zhao H, Wang X, Rao L, Ai W, Yu J, Guo Y, Wu X, Yu F, Chen S. In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from chinese hospitals in 2018\u20132020. Infection and drug resistance. 2021:5449\u201356. https:\/\/doi.org\/10.2147\/IDR.S340623.","DOI":"10.2147\/IDR.S340623"},{"key":"8397_CR62","doi-asserted-by":"publisher","unstructured":"Adamus-Bia\u0142ek W, Wawszczak M, Arabski M, Majchrzak M, Gulba M, Jarych D, Parniewski P, G\u0142uszek S. Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains. Virulence. 2019;10(1):260 \u2013 76. https:\/\/doi.org\/10.1080\/21505594.2019.1596507.","DOI":"10.1080\/21505594.2019.1596507"},{"key":"8397_CR63","doi-asserted-by":"publisher","unstructured":"Biedenbach DJ, Toleman MA, Walsh TR, Jones RN. Characterization of fluoroquinolone-resistant \u03b2-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997\u20132004). Diagnostic microbiology and infectious disease. 2006;55(2):119 \u2013 27. https:\/\/doi.org\/10.1016\/J.DIAGMICROBIO.2005.12.006.","DOI":"10.1016\/J.DIAGMICROBIO.2005.12.006"},{"key":"8397_CR64","doi-asserted-by":"publisher","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics. 2020;9(6):312. https:\/\/doi.org\/10.3390\/ANTIBIOTICS9060312.","DOI":"10.3390\/ANTIBIOTICS9060312"},{"key":"8397_CR65","doi-asserted-by":"publisher","unstructured":"Yashavanth R, Shiju MP, Bhaskar UA, Ronald R, Anita KB. Candiduria: prevalence and trends in antifungal susceptibility in a tertiary care hospital of Mangalore. J Clin Diagn Research: JCDR. 2013;7(11):2459. https:\/\/doi.org\/10.7860\/JCDR\/2013\/6298.3578.","DOI":"10.7860\/JCDR\/2013\/6298.3578"},{"key":"8397_CR66","doi-asserted-by":"crossref","unstructured":"Shaban S, Patel M, Ahmad A. Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris. Scientific reports. 2020;10(1):1162. Available from: https:\/\/www.nature.com\/articles\/s41598-020-58203-3.","DOI":"10.1038\/s41598-020-58203-3"},{"key":"8397_CR67","doi-asserted-by":"publisher","unstructured":"Quind\u00f3s G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, Eraso E. Therapeutic tools for oral candidiasis: current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal. 2019;24(2):e172. https:\/\/doi.org\/10.4317\/MEDORAL.22978.","DOI":"10.4317\/MEDORAL.22978"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08397-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08397-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:16:44Z","timestamp":1687425404000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08397-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8397"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08397-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"1 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This manuscript does not refer to or imply the use of any animal or human data or tissues. The research is based on the analysis of the data extracted from the laboratory information systems. Data were analyzed nameless, and results could not be traced back to individual patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"424"}}